Analystreport

Catalyst Biosciences (NASDAQ: CBIO) was given a new $44.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock.

Catalyst Biosciences, Inc.  (CBIO) 
Last catalyst biosciences, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors